Fycompa 2 mg film-coated tablets, Fycompa 2 mg film-coated tablets, Fycompa 0.5 mg/ml oral suspension, Fycompa 2 mg film-coated tablets
E2007-G000-236
Phase 2 small_molecule active
Quick answer
Fycompa 2 mg film-coated tablets, Fycompa 2 mg film-coated tablets, Fycompa 0.5 mg/ml oral suspension, Fycompa 2 mg film-coated tablets for Childhood Epilepsy is a Phase 2 program (small_molecule) at Eisai GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eisai GmbH
- Indication
- Childhood Epilepsy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active